Drug Database
PI

piperacillin (piperacillin, KRKA / Isipen)

✓ Approved

Krka · 小分子 · 小分子

什么是 piperacillin?

piperacillin 是一种小分子,由Krka研发。该药已获批,用于治疗相关适应症,给药途径:Unknown。

药物档案

商品名piperacillin, KRKA, Isipen
公司Krka
药物类别小分子
给药途径Unknown
状态Approved

治疗适应症

piperacillin 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Infections and infestationsSalmonellosis✓ Approved

相关研究文献

PubMedJournal of family & reproductive health2026-10-25

Edwardsiella tarda Bacteremia in Early Pregnancy Complicated by Maternal Sepsis and Intrauterine Fetal Demise: A Case Report.

Modi Uday U, Gupta Nitin N, Varma Muralidhar M, Vasudeva Akhila A et al.

To report a rare case of Edwardsiella tarda bacteremia in early pregnancy complicated by maternal sepsis, sepsis-induced coagulopathy, acute kidney injury, and intrauterine fetal demise. A 32-year-old woman at 13 weeks of gestation presented with sudden-onset high-grade fever, abdominal pain, and vaginal bleeding shortly after consuming freshwater fish. She had no preceding diarrhea or vomiting. During hospitalization, she developed persistent fever, anemia, thrombocytopenia, acute kidney injury, and coagulopathy, with a sepsis-induced coagulopathy score of 5. Obstetric ultrasonography confirmed absence of fetal cardiac activity, and emergency vacuum aspiration was performed. Blood cultures grew Edwardsiella tarda, while stool cultures were sterile. She was treated with intravenous piperacillin-tazobactam, fluid resuscitation, oxygen supplementation, and blood transfusion. Her fever subsided, renal function and coagulation parameters normalized, and she was discharged in stable condition. Invasive Edwardsiella tarda infection during pregnancy is extremely uncommon but may cause severe maternal sepsis and adverse fetal outcome even without gastrointestinal symptoms. Recent freshwater fish exposure may provide an important diagnostic clue. Early blood culture sampling, prompt antimicrobial therapy, and supportive care are essential for maternal recovery.

PMID 42923833
阅读全文 →
PubMedThe American journal of case reports2026-10-25

Streptococcus constellatus-Associated Lemierre Syndrome Presenting With Cavitating Septic Pulmonary Emboli Managed by Video-Assisted Thoracoscopy.

Fierro-Mosquera Andre A, Perez-Guerron Camila C, Llerena-Velastegui Jordan J, Jimbo-Sotomayor Ruth R et al.

BACKGROUND Lemierre syndrome is a rare septic thromboembolic disorder. Although historically associated with Fusobacterium necrophorum, non-fusobacterial cases caused by Streptococcus constellatus can present with dominant thoracic sepsis and delayed recognition. CASE REPORT A 25-year-old previously healthy man from northern Ecuador presented with 7 days of dyspnea, productive cough, fever, and hemoptysis, with profound hypoxemia and respiratory distress. Chest computed tomography showed bilateral cavitating septic pulmonary emboli and necrotizing pulmonary infection, and cervical vascular imaging confirmed left internal jugular vein thrombosis. One blood culture set grew Streptococcus constellatus susceptible to penicillin and ceftriaxone; sputum and pleural fluid cultures were sterile. He required intensive care, endotracheal intubation, empiric piperacillin-tazobactam plus vancomycin, escalation to meropenem plus vancomycin during clinical deterioration while resistant or polymicrobial infection was considered, therapeutic anticoagulation, and 2 video-assisted thoracoscopic procedures for empyema and a subsequent pulmonary abscess. After 4 weeks of intravenous antibiotics, he improved and was discharged on a direct oral anticoagulant for 1 additional month, remaining asymptomatic at short-term follow-up. CONCLUSIONS Lemierre syndrome should be considered in young adults with severe sepsis and multifocal cavitating lung lesions, even without pharyngeal symptoms. Empiric therapy should initially cover oral aerobes and anaerobes; once penicillin-susceptible Streptococcus constellatus is confirmed and no co-pathogen is recovered, de-escalation to targeted beta-lactam therapy, such as penicillin G or ceftriaxone, should be considered together with drainage of empyema or abscess when present.

PMID 42921992
阅读全文 →
PubMedAmerican journal of translational research2026-10-25

Emerging trends in multidrug-resistant ESBL-producing Escherichia coli in urinary tract infections: a clinical and genomic observational study from Kunshan city.

Qian Yingfen Y, Weng Yiwei Y, Zhao Jia J, Xiao Xingyuan X

With the global spread of extended-spectrum β-lactamase-producing Escherichia coli (ESBL-EC), treatment of urinary tract infections (UTIs) has become increasingly challenging. This study aimed to investigate the antimicrobial resistance patterns, genotypic characteristics, and clinical risk factors associated with ESBL-EC in UTI patients in Kunshan City. This retrospective observational study included 421 patients with culture-confirmed UTIs admitted to two hospitals in Kunshan (2022-2024). Clinical records and 465 bacterial isolates were analyzed. Bacterial identification and susceptibility testing were performed using standard culture and molecular genotyping. Resistance genotypes were identified via polymerase chain reaction (PCR)-based sequencing. Multivariate logistic regression and receiver operating characteristic (ROC) curve analysis were used to assess risk factors and treatment efficacy. Outcomes included resistance rates, ESBL genotype distribution, independent predictors of multidrug resistance (MDR), and treatment efficacy measured by area under the curve (AUC). ESBL-EC was the predominant pathogen, with high resistance to ampicillin (71.65%) and ciprofloxacin (38.19%), while retaining susceptibility to cefoperazone/sulbactam and piperacillin/tazobactam. CTX-M (7.87%) and PASE+CASE (36.61%) were the dominant genotypes. Independent MDR predictors included age ≥54 years, body mass index (BMI) ≥22.5 kg/m2, prior UTI, antibiotic use, prolonged hospitalization, and diabetes (OR=7.985). The aminoglycoside-cephalosporin combination showed the highest predictive value for recovery (AUC=0.872). ESBL-EC in UTIs shows increasing multidrug resistance and a unique local genotype landscape dominated by PASE+CASE (36.61%). Early risk stratification and region-specific empirical therapy are critical for resistance containment in this locality.

PMID 42923512
阅读全文 →
PubMedbioRxiv : the preprint server for biology2026-10-25

Microbial valerate is associated with CAR T dysbiosis and its supplementation enhances CAR T function in B-cell lymphoma.

Rehman Lubna L, Song Wenting W, Rehman Abdur A, Singh Kamini K et al.

Anaerobe-depleting antibiotic exposure is associated with inferior progression-free survival after CD19 CAR T-cell therapy in large B-cell lymphoma, yet the cellular mechanisms linking gut dysbiosis to the CAR T-cell product and whether this imprint is reversible have remained undefined. In two independent CAR-T candidate cohorts, low stool valerate at the time of CAR-T eligibility identified a multi-metabolite-deficient dysbiotic gut microbiome state marked by depletion of fiber-fermenting commensals and loss of carbohydrate-fermentation, SCFA-biosynthesis, and amino-acid metabolism pathways. Reanalysis of single-cell RNA sequencing from 42 lymphoma patients stratified by piperacillin-tazobactam/imipenem/meropenem (PIM) exposure revealed that PIM-exposed CAR T-cell products were CD4-skewed, with significantly elevated AP-1/immediate-early gene (IEG) and cellular activation signatures that together predicted inferior progression-free survival. Ex vivo conditioning of CAR T-cells with valerate produced a chromatin and transcription factor program distinct from butyrate or propionate, characterized by KLF/SP/EGR family engagement, KLF4 promoter opening, and broad induction of AP-1/IEG and MHC class II transcripts, whereas butyrate drove broader chromatin remodeling with TBX21/EOMES/NF-κB gains and KLF2 promoter closure, and propionate induced an NFY-centered program with preferential commitment to low-mitochondrial-content states. Untargeted metabolomics confirmed valerate uptake and mitochondrial β-oxidation in CAR T-cells, while dietary sodium valerate supplementation in meropenem-treated mice bearing A20 lymphoma significantly reduced tumor burden and extended survival compared with CAR T-cells alone. These findings identify stool valerate as a bedside-deployable biomarker of dysbiosis-imprinted CAR T-cell dysfunction and support ex vivo or dietary valerate supplementation as a clinically tractable strategy to improve CAR-T anti-tumor function in patients with disrupted gut microbiomes.

PMID 42922635
阅读全文 →
PubMedCureus2026-10-25

Antimicrobial Resistance of Bacteria Isolated From Patients With Cancer.

Valente-Morales Yetzil Y, Quintana-Ponce Sandra S, Kuri-Guinto Margarita Y MY, Díaz-Gonzaléz Sacnite D SD et al.

Cancer patients are at high risk of developing infections caused by multidrug-resistant (MDR) microorganisms. Monitoring antimicrobial resistance (AMR) is essential for guiding treatment in this vulnerable population. This study aimed to evaluate AMR patterns and temporal evolution among clinical bacterial isolates-comparing pre-pandemic (2016-2019) versus pandemic (2020-2021) periods and care settings (outpatient vs. inpatient)-recovered from cancer patients at a tertiary care center in Guerrero, Mexico. An observational, cross-sectional, retrospective study was conducted between 2016 and 2021. A total of 1,019 strains were analyzed using WHONET 2023 software, following the Clinical and Laboratory Standards Institute (CLSI) M100 cut-off values. Categorical variables were compared using Pearson's chi-squared test (χ²). For antibiotics with absolute frequencies less than 5, Fisher's exact test was applied using STATA statistical software version 14.2 (StataCorp LLC, College Station, TX, USA). Enterobacteriaceae accounted for 73.1% of the isolates, with Escherichia coli (42.3%, n = 431) and Klebsiella pneumoniae (14.0%, n = 143) being the predominant strains. The overall prevalence of extended-spectrum beta-lactamases (ESBLs) was 22.6%. In E. coli, an increase in resistance was observed starting in 2019, with resistance rates > 80.0% for ampicillin and cefixime. When comparing the 2020 period with 2021, resistance in E. coli increased significantly for ciprofloxacin (χ² = 4.144, p = 0.042) and ceftriaxone (χ² = 4.100, p = 0.043). Regarding MDR, 51.0% of E. coli isolates were MDR, while 32.2% of K. pneumoniae strains exhibited extensive drug resistance (XDR). In addition, possible pandrug-resistant (PDR) phenotypes were identified in 14.3% of Acinetobacter spp. isolates. Isolates from hospitalized patients showed higher resistance rates compared to those from outpatients with regard to E. coli for ampicillin/sulbactam (χ² = 4.422, p = 0.035), piperacillin/tazobactam (χ² = 17.519, p < 0.001), and cefazolin (χ² = 6.746, p = 0.009). The results demonstrate a high predominance of Enterobacteriaceae among clinical bacterial isolates from the evaluated oncology population. E. coli exhibited the highest proportion of MDR phenotypes (51.0%), whereas K. pneumoniae showed the highest frequency of XDR (32.2%). The high level of resistance observed among isolates from hospitalized patients could help guide empirical treatment toward alternative therapeutic options.

PMID 42927103
阅读全文 →
PubMedInternational ophthalmology2026-10-23

Bacterial and fungal pathogens in adult dacryocystitis: a retrospective study from a tertiary medical center in southern Taiwan.

Hsieh Ai-Hua AH, Chi Yi-Chun YC, Hsu Huai-Wen HW, Lai Chun-Chieh CC

To investigate the microbiological spectrum of dacryocystitis in southern Taiwan, with emphasis on polymicrobial and fungal infections, and to inform treatment based on regional susceptibility patterns. This retrospective study enrolled patients with culture-proven dacryocystitis who underwent lacrimal surgery at a tertiary medical center in southern Taiwan from 2014 to 2024. Routine fungal culture was implemented after July 2018. Only intraoperative specimens obtained under sterile conditions were analyzed to minimize contamination. Among 216 dacryocystitis cases (102 acute and 114 chronic), 179 (82.9%) were culture-positive. Staphylococcus aureus and Cutibacterium acnes were commonly identified in acute cases, whereas Pseudomonas aeruginosa and S. epidermidis were more frequent in chronic cases. After routine fungal culture was implemented, fungi were detected in 19 of 154 cases (12.3%), predominantly in chronic cases. Oxacillin resistance was observed in 13 of 36 S. aureus isolates (36.1%), while most Gram-negative isolates remained susceptible to gentamicin, amikacin, and piperacillin-tazobactam. Our findings demonstrate a diverse microbial spectrum in adult dacryocystitis, including Gram-negative, polymicrobial, and fungal involvement, particularly in chronic disease. The observed antimicrobial resistance patterns suggest that Gram-positive-focused empirical therapy may not provide adequate coverage. Comprehensive microbiological evaluation, including fungal culture, together with consideration of local susceptibility patterns may improve treatment selection, particularly in chronic or refractory dacryocystitis.

PMID 42909527
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多piperacillin